The progression of myopic maculopathy may affect the long-term VA outcome of myopic CNV treatment. We evaluated the long-term progression of myopic maculopathy and functional outcome after treatment of myopic choroidal neovascularization (CNV) with photodynamic therapy (PDT) and/or intravitrealranibizumab (IVR). This was a retrospective study with a cross-sectional evaluation, including fifty-four eyes with a mean follow-up of 80.6 ± 28.0...

Read More